|
[1]
|
Gonzalez-Meljem, J.M., Cao, L., Apps, J.R. and Martinez-Barbera, J.P. (2025) Decoding Craniopharyngioma: From Mechanisms to Therapy. Best Practice & Research Clinical Endocrinology & Metabolism, 39, Article ID: 102051. [Google Scholar] [CrossRef]
|
|
[2]
|
Apps, J.R., Carreno, G., Gonzalez-Meljem, J.M., Haston, S., Guiho, R., Cooper, J.E., et al. (2018) Tumour Compartment Transcriptomics Demonstrates the Activation of Inflammatory and Odontogenic Programmes in Human Adamantinomatous Craniopharyngioma and Identifies the MAPK/ERK Pathway as a Novel Therapeutic Target. Acta Neuropathologica, 135, 757-777. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
An, W., Li, S., An, Y. and Lin, Z. (2025) Molecular Subtypes of Adamantinomatous Craniopharyngiomas. Neuro-Oncology, 27, 1180-1192. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Pires de Oliveira Neto, C., Nascimento, G.C., Damianse, S.d.S.P. and Faria, M.d.S. (2025) Recent Advances in Craniopharyngioma Pathophysiology and Emerging Therapeutic Approaches. Frontiers in Endocrinology, 16, Article ID: 1562942. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Apps, J.R., Gonzalez-Meljem, J.M., Guiho, R., Pickles, J.C., Prince, E., Schwalbe, E., et al. (2024) Recurrent Adamantinomatous Craniopharyngiomas Show MAPK Pathway Activation, Clonal Evolution and Rare Tp53-Loss-Mediated Malignant Progression. Acta Neuropathologica Communications, 12, Article No. 127. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Lin, D., Wang, Y., Zhou, Z., et al. (2019) Immune Microenvironment of Primary and Recurrent Craniopharyngiomas: A Study of the Differences and Clinical Significance. World Neurosurgery, 126, e1056-e1063.
|
|
[7]
|
Gao, Q., Luo, J., Pan, J., Zhang, L., Song, D., Zhang, M., et al. (2022) Integrative Analyses Identify Hif-1α as a Potential Protective Role with Immune Cell Infiltration in Adamantinomatous Craniopharyngioma. Frontiers in Immunology, 13, Article ID: 949509. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Xu, C., Wu, J., Ye, J., Si, Y., Zhang, J., Wu, B., et al. (2024) Multiomics Integration-Based Immunological Characterizations of Adamantinomatous Craniopharyngioma in Relation to Keratinization. Cell Death & Disease, 15, Article No. 439. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Coy, S., Rashid, R., Lin, J., Du, Z., Donson, A.M., Hankinson, T.C., et al. (2018) Multiplexed Immunofluorescence Reveals Potential PD-1/PD-L1 Pathway Vulnerabilities in Craniopharyngioma. Neuro-Oncology, 20, 1101-1112. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Jiang, Y., Yang, J., Liang, R., Zan, X., Fan, R., Shan, B., et al. (2023) Single-Cell RNA Sequencing Highlights Intratumor Heterogeneity and Intercellular Network Featured in Adamantinomatous Craniopharyngioma. Science Advances, 9, eadc8933. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Matsuda, T., Kono, T., Taki, Y., Sakuma, I., Fujimoto, M., Hashimoto, N., et al. (2024) Deciphering Craniopharyngioma Subtypes: Single-Cell Analysis of Tumor Microenvironment and Immune Networks. iScience, 27, Article ID: 111068. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Zhang, B., Zhang, J., Li, Z., Sheng, H., Li, H., Lu, Y., et al. (2025) Interrogation of the Cellular Hierarchies Reveals Neoplastic Evolution and Therapeutic Vulnerability in Craniopharyngioma. Neuro-Oncology, 28, 191-205. [Google Scholar] [CrossRef]
|
|
[13]
|
Kang, M., Gulati, G.S., Brown, E.L., Qi, Z., Avagyan, S., Armenteros, J.J.A., et al. (2025) Improved Reconstruction of Single-Cell Developmental Potential with Cytotrace 2. Nature Methods, 22, 2258-2263. [Google Scholar] [CrossRef]
|
|
[14]
|
Gulati, G.S., Sikandar, S.S., Wesche, D.J., Manjunath, A., Bharadwaj, A., Berger, M.J., et al. (2020) Single-Cell Transcriptional Diversity Is a Hallmark of Developmental Potential. Science, 367, 405-411. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Dimitrov, D., Türei, D., Garrido-Rodriguez, M., Burmedi, P.L., Nagai, J.S., Boys, C., et al. (2022) Comparison of Methods and Resources for Cell-Cell Communication Inference from Single-Cell RNA-Seq Data. Nature Communications, 13, Article No. 3224. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Dimitrov, D., Schäfer, P.S.L., Farr, E., Rodriguez-Mier, P., Lobentanzer, S., Badia-i-Mompel, P., et al. (2024) LIANA+ Provides an All-in-One Framework for Cell-Cell Communication Inference. Nature Cell Biology, 26, 1613-1622. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Ji, S., Shi, Y. and Yin, B. (2024) Macrophage Barrier in the Tumor Microenvironment and Potential Clinical Applications. Cell Communication and Signaling, 22, Article No. 74. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Toledo, B., Zhu Chen, L., Paniagua-Sancho, M., Marchal, J.A., Perán, M. and Giovannetti, E. (2024) Deciphering the Performance of Macrophages in Tumour Microenvironment: A Call for Precision Immunotherapy. Journal of Hematology & Oncology, 17, Article No. 44. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Jhunjhunwala, S., Hammer, C. and Delamarre, L. (2021) Antigen Presentation in Cancer: Insights into Tumour Immunogenicity and Immune Evasion. Nature Reviews Cancer, 21, 298-312. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Dhatchinamoorthy, K., Colbert, J.D. and Rock, K.L. (2021) Cancer Immune Evasion through Loss of MHC Class I Antigen Presentation. Frontiers in Immunology, 12, Article ID: 636568. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Balasubramanian, A., John, T. and Asselin-Labat, M. (2022) Regulation of the Antigen Presentation Machinery in Cancer and Its Implication for Immune Surveillance. Biochemical Society Transactions, 50, 825-837. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Zhang, H., Li, S., Wang, D., Liu, S., Xiao, T., Gu, W., et al. (2024) Metabolic Reprogramming and Immune Evasion: The Interplay in the Tumor Microenvironment. Biomarker Research, 12, Article No. 96. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Tufail, M., Jiang, C. and Li, N. (2025) Immune Evasion in Cancer: Mechanisms and Cutting-Edge Therapeutic Approaches. Signal Transduction and Targeted Therapy, 10, Article No. 227. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Wang, R., Zhuang, J., Zhang, Q., Wu, W., Yu, X., Zhang, H., et al. (2025) Decoding the Metabolic Dialogue in the Tumor Microenvironment: From Immune Suppression to Precision Cancer Therapies. Experimental Hematology & Oncology, 14, Article No. 99. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Ma, G., Zhang, Z., Li, P., Zhang, Z., Zeng, M., Liang, Z., et al. (2022) Reprogramming of Glutamine Metabolism and Its Impact on Immune Response in the Tumor Microenvironment. Cell Communication and Signaling, 20, Article No. 114. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Prince, E.W., Apps, J.R., Jeang, J., Chee, K., Medlin, S., Jackson, E.M., et al. (2024) Unraveling the Complexity of the Senescence-Associated Secretory Phenotype in Adamantinomatous Craniopharyngioma Using Multimodal Machine Learning Analysis. Neuro-Oncology, 26, 1109-1123. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Guo, R., Wang, R., Zhang, W., Li, Y., Wang, Y., Wang, H., et al. (2025) Multifaceted Regulatory Mechanisms of the EGR Family in Tumours and Prospects for Therapeutic Applications (Review). International Journal of Molecular Medicine, 56, Article No. 113. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Pagin, M., Pernebrink, M., Giubbolini, S., Barone, C., Sambruni, G., Zhu, Y., et al. (2021) Sox2 Controls Neural Stem Cell Self-Renewal through a Fos-Centered Gene Regulatory Network. Stem Cells, 39, 1107-1119. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Regan, J.L., Schumacher, D., Staudte, S., Steffen, A., Lesche, R., Toedling, J., et al. (2022) Identification of a Neural Development Gene Expression Signature in Colon Cancer Stem Cells Reveals a Role for EGR2 in Tumorigenesis. iScience, 25, Article ID: 104498. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Buchou, C., Laud-Duval, K., van der Ent, W., Grossetête, S., Zaidi, S., Gentric, G., et al. (2022) Upregulation of the Mevalonate Pathway through EWSR1-FLI1/EGR2 Regulatory Axis Confers Ewing Cells Exquisite Sensitivity to Statins. Cancers, 14, Article No. 2327. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Talukdar, S., Emdad, L., Das, S.K., et al. (2020) EGFR: An Essential Receptor Tyrosine Kinase-Regulator of Cancer Stem Cells. Advances in Cancer Research, 147, 161-188.
|
|
[32]
|
Uribe, M.L., Marrocco, I. and Yarden, Y. (2021) EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance. Cancers, 13, Article No. 2748. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Yang, J., Liao, D., Chen, C., Liu, Y., Chuang, T., Xiang, R., et al. (2013) Tumor-Associated Macrophages Regulate Murine Breast Cancer Stem Cells through a Novel Paracrine EGFR/Stat3/Sox-2 Signaling Pathway. Stem Cells, 31, 248-258. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Klimaschewski, L. and Claus, P. (2021) Fibroblast Growth Factor Signalling in the Diseased Nervous System. Molecular Neurobiology, 58, 3884-3902. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Ardizzone, A., Scuderi, S.A., Giuffrida, D., Colarossi, C., Puglisi, C., Campolo, M., et al. (2020) Role of Fibroblast Growth Factors Receptors (FGFRs) in Brain Tumors, Focus on Astrocytoma and Glioblastoma. Cancers, 12, Article No. 3825. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Babina, I.S. and Turner, N.C. (2017) Advances and Challenges in Targeting FGFR Signalling in Cancer. Nature Reviews Cancer, 17, 318-332. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Zhang, P., Yue, L., Leng, Q., Chang, C., Gan, C., Ye, T., et al. (2024) Targeting FGFR for Cancer Therapy. Journal of Hematology & Oncology, 17, Article No. 39. [Google Scholar] [CrossRef] [PubMed]
|